BioSpace News Archive

CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that multiple seladelpar presentations will be delivered during The International Liver Congress™ 2021 of the European Association for the Study of Liver.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces that CEO Dr. William V. Williams will host a corporate and clinical update call on Wednesday, June 16, 2021 at 4:30 p.m. ET.

Starton Therapeutics Inc., a clinical stage biotechnology company transforming standard of care therapies with proprietary transdermal technology, today announced that it has developed several formulations to successfully deliver lenalidomide across the skin.

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that an abstract featuring new preclinical data for its IRAKIMiD degrader KT-413 has been selected for oral presentation at the 16th Annual International Conference.

China Pharma Holdings, Inc., a specialty pharmaceutical company, announced plans to launch a highly purified NMN+PQQ product following the recent successful completion of a pilot scale test.

LIPAC Oncology LLC., today announced the positive results from the two-year follow-up for TD-001, its Phase 1/2a study of LiPax in patients with non-muscle invasive bladder cancer (NMIBC) who have undergone transurethral resection of bladder tumor (TURBT)

Harmony reinforces its commitment to supporting the needs of people affected by sleep disorders and rare diseases

Selva Therapeutics, Inc. (“Selva”) announced that its antiviral drug candidate SLV213 has been shown to be effective against three prominent variants of SARS-CoV-2.

ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, announces that it is expected to be added to the Russell Microcap® Index according to a preliminary list of additions posted on June 4.

Biotricity, Inc. today announced that it will release its financial results for the fourth quarter and full fiscal year 2021, ended March 31, 2021, on Tuesday, June 15, 2021.